Total Payments
$6,280
2024 Payments
$1,901
Companies
41
Transactions
474
Medicare Patients
2,533
Medicare Billing
$114,983
Payment Breakdown by Category
Food & Beverage$6,280 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,280 | 474 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,324 | 163 | $0 (2024) |
| Novo Nordisk Inc | $761.00 | 86 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $499.15 | 34 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $495.08 | 24 | $0 (2024) |
| Lilly USA, LLC | $382.94 | 21 | $0 (2024) |
| Abbott Laboratories | $351.92 | 19 | $0 (2024) |
| Amgen Inc. | $343.36 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $226.84 | 6 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $226.69 | 12 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $147.10 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,901 | 114 | Otsuka America Pharmaceutical, Inc. ($366.20) |
| 2023 | $1,402 | 118 | ABBVIE INC. ($378.92) |
| 2022 | $1,495 | 121 | ABBVIE INC. ($399.90) |
| 2021 | $1,482 | 121 | Novo Nordisk Inc ($336.18) |
All Payment Transactions
474 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $31.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 569 | 977 | $127,124 | $25,847 |
| 2022 | 16 | 640 | 925 | $155,654 | $32,016 |
| 2021 | 15 | 741 | 1,066 | $174,974 | $36,061 |
| 2020 | 16 | 583 | 789 | $118,464 | $21,059 |
Total Patients
2,533
Total Services
3,757
Medicare Billing
$114,983
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 175 | $57,915 | $12,039 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 23 | $10,224 | $2,361 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 50 | $11,409 | $2,358 | 20.7% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 16 | 16 | $9,128 | $2,236 | 24.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $5,624 | $1,734 | 30.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $9,017 | $1,401 | 15.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $5,899 | $915.83 | 15.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 79 | 106 | $954.00 | $890.40 | 93.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 89 | $5,987 | $672.89 | 11.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 23 | 24 | $3,182 | $478.38 | 15.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 40 | 45 | $3,915 | $342.45 | 8.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 30 | $2,354 | $209.87 | 8.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 37 | 41 | $428.04 | $139.81 | 32.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 26 | 108 | $216.00 | $35.14 | 16.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 14 | $56.00 | $17.01 | 30.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 30 | 204 | $816.00 | $15.63 | 1.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 200 | $66,188 | $13,210 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 71 | $16,201 | $3,677 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $16,532 | $3,316 | 20.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 22 | $9,779 | $2,583 | 26.4% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 16 | 17 | $9,699 | $2,381 | 24.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $6,327 | $2,027 | 32.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $6,226 | $1,409 | 22.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 37 | 40 | $10,000 | $1,403 | 14.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 32 | 64 | $4,305 | $532.99 | 12.4% |
About Shawn Garcia, PA-C
Shawn Garcia, PA-C is a Physician Assistant healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1306142906.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shawn Garcia, PA-C has received a total of $6,280 in payments from pharmaceutical and medical device companies, with $1,901 received in 2024. These payments were reported across 474 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($6,280).
As a Medicare-enrolled provider, Garcia has provided services to 2,533 Medicare beneficiaries, totaling 3,757 services with total Medicare billing of $114,983. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Brooklyn, NY
- Active Since 01/31/2011
- Last Updated 01/31/2011
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306142906
Products in Payments
- VRAYLAR (Drug) $952.90
- REXULTI (Drug) $588.70
- Kerendia (Drug) $499.15
- Ozempic (Drug) $418.87
- NUZYRA (Drug) $226.69
- FREESTYLE LIBRE 2 (Device) $200.30
- QULIPTA (Drug) $195.01
- UBRELVY (Drug) $175.93
- Aimovig (Biological) $169.83
- Otezla (Drug) $159.22
- FREESTYLE LIBRE 3 (Device) $151.62
- TRINTELLIX (Drug) $147.10
- BREZTRI (Drug) $143.20
- TRULICITY (Drug) $126.98
- EMGALITY (Drug) $121.36
- TRELEGY ELLIPTA (Drug) $120.40
- Rybelsus (Drug) $118.75
- Wegovy (Drug) $110.80
- NURTEC ODT (Drug) $101.00
- MOUNJARO (Drug) $100.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Brooklyn
Kaitlyn Nelson, Pa-C, PA-C
Physician Assistant — Payments: $262,844
Physician Assistant $262,844
Steven Kong
Physician Assistant — Payments: $55,299
Physician Assistant $55,299
Mrs. Melissa Velez, Rpa-C, RPA-C
Physician Assistant — Payments: $53,018
Physician Assistant $53,018
Hong Chen
Physician Assistant — Payments: $47,002
Physician Assistant $47,002
Gregory Celestin, Pa, PA
Physician Assistant — Payments: $30,181
Physician Assistant $30,181
Lindsey Axt, Pa-C, PA-C
Physician Assistant — Payments: $26,935
Physician Assistant $26,935